Table 14.2

Recipient Recurrence of Pretransplant Malignancies, 1995 to 2004

by Transplant Type

Organ Type Year of Transplant
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Total Total Recipients 19,411 19,768 20,319 21,537 22,042 23,257 24,237 24,915 25,478 27,044
# With Pre-Tx Malignancy (1) 360 443 480 567 738 867 997 1,194 1,206 1,254
# With Recurrence of Pre-Tx Malignancy (2) 9 10 21 20 55 43 39 49 29 11
% With Recurrence of Pre-Tx Malignancy (3) 2.5% 2.3% 4.4% 3.5% 7.5% 5.0% 3.9% 4.1% 2.4% 0.9%
# With Recurrence, but no Pre-Tx Malignancy (4) 24 30 37 58 26 29 48 43 43 19
Kidney Total Recipients 11,078 11,398 11,701 12,446 12,756 13,611 14,263 14,777 15,134 16,000
# With Pre-Tx Malignancy (1) 165 200 233 262 328 347 423 463 468 503
# With Recurrence of Pre-Tx Malignancy (2) 1 2 7 3 13 8 3 7 4 3
% With Recurrence of Pre-Tx Malignancy (3) 0.6% 1.0% 3.0% 1.1% 4.0% 2.3% 0.7% 1.5% 0.9% 0.6%
# With Recurrence, but no Pre-Tx Malignancy (4) 4 7 7 8 7 8 8 3 7 2
Pancreas Transplant Alone Total Recipients 42 52 79 88 137 135 165 177 159 185
# With Pre-Tx Malignancy (1) 1 1 1 2 3 5 7 5 5 5
# With Recurrence of Pre-Tx Malignancy (2) - - - - - 1 1 - - -
% With Recurrence of Pre-Tx Malignancy (3) - - - - - 20.0% 14.3% - - -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - - - - - - - -
Pancreas After Kidney Total Recipients 67 113 130 157 221 303 307 377 343 419
# With Pre-Tx Malignancy (1) - - 2 1 3 8 8 8 4 10
# With Recurrence of Pre-Tx Malignancy (2) - - - - - - - - - -
% With Recurrence of Pre-Tx Malignancy (3) - - - - - - - - - -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - - - - - - - -
Kidney-Pancreas Total Recipients 919 861 853 972 943 914 891 905 870 880
# With Pre-Tx Malignancy (1) 8 5 4 9 11 8 13 9 7 8
# With Recurrence of Pre-Tx Malignancy (2) 1 - - - - - - - - -
% With Recurrence of Pre-Tx Malignancy (3) 12.5% - - - - - - - - -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - - - - 1 1 - -
Liver Total Recipients 3,934 4,081 4,185 4,516 4,751 4,989 5,188 5,331 5,671 6,168
# With Pre-Tx Malignancy (1) 115 152 148 192 296 398 411 608 603 594
# With Recurrence of Pre-Tx Malignancy (2) 5 5 13 17 38 30 34 41 23 8
% With Recurrence of Pre-Tx Malignancy (3) 4.3% 3.3% 8.8% 8.9% 12.8% 7.5% 8.3% 6.7% 3.8% 1.3%
# With Recurrence, but no Pre-Tx Malignancy (4) 16 20 28 43 19 19 37 36 35 16
Intestine Total Recipients 46 45 68 70 73 81 111 107 116 152
# With Pre-Tx Malignancy (1) 1 2 3 3 1 4 4 4 6 9
# With Recurrence of Pre-Tx Malignancy (2) - - - - - 1 1 - 1 -
% With Recurrence of Pre-Tx Malignancy (3) - - - - - 25.0% 25.0% - 16.7% -
# With Recurrence, but no Pre-Tx Malignancy (4) 1 - - - - - - - - -
Heart Total Recipients 2,363 2,343 2,293 2,348 2,188 2,199 2,202 2,155 2,057 2,016
# With Pre-Tx Malignancy (1) 58 60 72 73 74 68 95 62 76 87
# With Recurrence of Pre-Tx Malignancy (2) 2 3 1 - 3 1 - - 1 -
% With Recurrence of Pre-Tx Malignancy (3) 3.4% 5.0% 1.4% - 4.1% 1.5% - - 1.3% -
# With Recurrence, but no Pre-Tx Malignancy (4) - 2 1 4 - 2 1 2 - -
Lung Total Recipients 893 836 948 893 922 977 1,083 1,054 1,099 1,185
# With Pre-Tx Malignancy (1) 12 23 17 25 22 28 34 34 34 37
# With Recurrence of Pre-Tx Malignancy (2) - - - - 1 2 - 1 - -
% With Recurrence of Pre-Tx Malignancy (3) - - - - 4.5% 7.1% - 2.9% - -
# With Recurrence, but no Pre-Tx Malignancy (4) 3 1 1 3 - - 1 1 1 1
Heart-Lung Total Recipients 69 39 62 47 51 48 27 32 29 39
# With Pre-Tx Malignancy (1) - - - - - 1 2 1 3 1
# With Recurrence of Pre-Tx Malignancy (2) - - - - - - - - - -
% With Recurrence of Pre-Tx Malignancy (3) - - - - - - - - - -
# With Recurrence, but no Pre-Tx Malignancy (4) - - - - - - - - - -


Source: OPTN/SRTR Data as of May 2, 2005.

(-) = None in category.

Includes both deceased and living donor transplants.

(1) Pre-Tx malignancy reported on the TCR or TRR Form.

(2) Recurrence reported on the Transplant Recipient Follow-up Form.

(3) Percent recurrence is calculated based on total with reported pre-tx malignancy.

(4) Recurrence reported on the follow-up form, but no pre-tx malignancy reported, so these are not included in recurrence rates.

Recipient malignancy statistics are based on voluntary reporting to the OPTN